In addition, kaempferol reduces iNOS, COX-2, and IL-18 formation by preventing NF-κB, p38 phosphorylation and NLRP3 inflammasome activation in the SN of PD rats caused by 6-OHDA [148]. Here, NFKB1 is linked to Parkinson disease.